Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER) — Stella

Home/Alzheimer Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Trial locations(1 site)

China

Chinese PLA General Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Chinese PLA General Hospital

Enrollment target

~750 participants

Started

July 2025

Primary completion

July 2029

Age range

55 Years – 90 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.